Imaging the cellular biology of the carotid plaque

International Journal of Stroke

Volumn 2, Issue 2, 2007, Pages 85-96

  U King Im, Jean Marie ^a   Tang, Tjun ^a   Moustafa, Ramez R ^a   Baron, Jean Claude ^a   Warburton, Elizabeth A ^a   Gillard, Jonathan H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Biochemical technology; Carotid atherosclerotic disease; Carotid plaque; Cellular biology; Imaging

Indexed keywords

CATHEPSIN B; CONTRAST MEDIUM; DIADENOSINE TETRAPHOSPHATE; EP 1873; EP 2104R; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; LOW DENSITY LIPOPROTEIN; MATRIX METALLOPROTEINASE; SIMVASTATIN; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN RECEPTOR;

APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; BRAIN ANGIOGRAPHY; CAROTID ARTERY DISEASE; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET THERAPY; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE COURSE; DISEASE SEVERITY; DRUG HALF LIFE; DRUG UPTAKE; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REPRODUCIBILITY; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE;

CAROTID ARTERY DISEASES; DIAGNOSTIC IMAGING; HUMANS;

EID: 34247855177     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2007.00123.x     Document Type: Review

References (77)

1. Rothwell PM, Buchan A, Johnston SC: Recent advances in management of transient ischaemic attacks and minor ischaemic strokes. Lancet Neurol 2006; 5: 323-31.
2. Warlow C, Sudlow C, Dennis M, Wardlaw J, Sandercock P: Stroke. Lancet 2003; 362: 1211-24.
3. Rothwell PM, Eliasziw M, Gutnikov SA et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.
4. Yadav JS, Wholey MH, Kuntz RE et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-501.
5. European Carotid Surgery Trialists Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European carotid surgery trial (ECST). Lancet 1998; 351: 1379-87.
6. Barnett HJ, Taylor DW, Eliasziw M et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American symptomatic carotid endarterectomy trial collaborators. N Eng J Med 1998; 339: 1415-25.
7. U-King-Im J, Hollingworth W, Trivedi RA et al. Cost-effectiveness of diagnostic strategies prior to carotid endarterectomy. Ann Neurol 2005; 58: 506-15.
8. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-5.
9. Trivedi RA, U-King-Im JM, Graves MJ, Gillard J, Kirkpatrick PJ: Non-stenotic ruptured atherosclerotic plaque causing thrombo-embolic stroke. Cerebrovasc Dis 2005; 20: 53-5.
10. Halliday A, Mansfield A, Marro J et al. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial. Lancet 2004; 363: 1491-502.
11. Yuan C, Miller ZE, Cai J, Hatsukami T: Carotid atherosclerotic wall imaging by MRI. Neuroimag Clin N Am 2002; 12: 391-401.
12. Trivedi RA, U-King-Im J, Graves MJ et al. Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. Eur J Vasc Endovasc Surg 2004; 28: 207-13.
13. Trivedi RA, U-King-Im JM, Graves MJ: MRI-derived measurements of fibrous-cap and lipid-core thickness: The potential for identifying vulnerable carotid plaques in vivo. Neuroradiology 2004; 46: 738-43.
14. Virmani R, Ladich ER, Burke AP, Kolodgie FD: Histopathology of carotid atherosclerotic disease. Neurosurgery 2006; 59: S219-27.
15. Takaya N, Yuan C, Chu B et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: A prospective assessment with MRI - initial results. Stroke 2006; 37: 818-23.
16. Yuan C, Zhang SX, Polissar NL et al. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation 2002; 105: 181-5.
17. Libby P: Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
18. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-95.
19. Jaffer FA, Weissleder R: Molecular imaging in the clinical arena. JAMA 2005; 293: 855-62.
20. Tahara N, Kai H, Ishibashi M et al. Simvastatin attenuates plaque inflammation: Evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006; 48: 1825-31.
21. Glass CK, Witztum JL: Atherosclerosis the road ahead. Cell 2001; 104: 503-16.
22. Libby P: Vascular biology of atOerosclerosis: overview and state of the art. Am J Cardiol 2003; 91: 3A-6A.
23. Fuster V, Fallon JT, Nemerson Y: Coronary thrombosis. Lancet 1996; 348 (Suppl. 1): S7-10.
24. Spagnoli LG, Mauriello A, Sangiorgi G et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004; 292: 1845-52.
25. Aikawa M, Libby P: The vulnerablePatherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004; 13: 125-38.
26. Libby P, Aikawa M, Jain MK: Vascular endothelium and atherosclerosis. Handb Exp Pharmacol 2006; 176: 285-306.
27. Aikawa M, Libby P: AtheroscleroTic plaque inflammation: the final frontier? Can J Cardiol 2004; 20: 631-4.
28. Libby P: Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr 2006; 83: 456S-60S.
29. Libby P, Ridker PM: Inflammation and atherothrombosis from population biology and bench research to clinical practice. J Am Coll Cardiol 2006; 48: A33-46.
30. Moreno PR, Purushothaman KR, Sirol M, Levy AP, Fuster V: Neovascularization in human atherosclerosis. Circulation 2006; 113: 2245-52.
31. Fishbein MC, Siegel RJ: How big are coronary atherosclerotic plaques that rupture? Circulation 1996; 94: 2662-6.
32. Lovett JK, Gallagher PJ, Hands LJ, Walton J, Rothwell PM: Histological correlates of carotid plaque surface morphology on lumen contrast imaging. Circulation 2004; 110: 2190-7.
33. Miralles M, Merino J, Busto M, Perich X, Barranco C, Vidal-Barraquer F: Quantification and characterization of carotid calcium with multi-detector CT-angiography. Eur J Vasc Endovasc Surg 2006; 32: 561-7.
34. Mathiesen EB, Bonaa KH, Joakimsen O: Echolucent plaques are associated with high risk of ischemic cerebrovascular events in carotid stenosis: the tromso study. Circulation 2001; 103: 2171-5.
35. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M: Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation 2007; 115: 459-67.
36. Nissen SE, Nicholls SJ, Sipahi I et al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: The ASTEROID trial. JAMA 2006; 295: 1556-65.
37. Corti R, Fayad ZA, Fuster V et al. Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: A longitudinal study by high-resolution, noninvasive magnetic resonance imaging. Circulation 2001; 104: 249-52.
38. Trivedi RA, U-King-Im J, Graves MJ, Kirkpatrick PJ, Gillard JH: Noninvasive imaging of carotid plaque inflammation. Neurology 2004; 63: 187-8.
39. Kooi ME, Cappendijk VC, Cleutjens KB et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 2003; 107: 2453-8.
40. Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B: Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging 2001; 14: 355-61.
41. Schmitz SA, Coupland SE, Gust R et al. Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol 2000; 35: 460-71.
42. Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF: Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001; 103: 415-22.
43. Trivedi RA, Mallawarachi C, U-King-Im J et al. Identifying inflamed carotid plaques using in vivo USPIO-enhanced MR imaging to label plaque macrophages. Arterioscler Thromb Vasc Biol 2006; 26: 1601-6.
44. Trivedi RA, U-King-Im J, Graves MJ et al. In vivo detection of macrophages in human carotid atheroma: Temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke 2004; 35: 1631-5.
45. Tang T, Howarth SP, Miller SR et al. Assessment of inflammatory burden contralateral to the symptomatic carotid stenosis using high-resolution ultrasmall, superparamagnetic iron oxide-enhanced MRI. Stroke 2006; 37: 2266-70.
46. Mani V, Briley-Saebo KC, Itskovich VV, Samber DD, Fayad ZA: Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): Sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T. Magn Reson Med 2006; 55: 126-35.
47. Lipinski MJ, Amirbekian V, Frias JC et al. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor. Magn Reson Med 2006; 56: 601-10.
48. Amirbekian V, Lipinski MJ, Briley-Saebo KC et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis non-invasively using molecular MRI. Proc Natl Acad Sci USA 2007; 104: 961-6.
49. Yun M, Yeh D, Araujo LI, Jang S, Newberg A, Alavi A: F-18 FDG uptake in the large arteries: A new observation. Clin Nucl Med 2001; 26: 314-9.
50. VallabhajosIla S, Fuster V: Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. J Nucl Med 1997; 38: 1788-96.
51. de Leeuw K, Bijl M, Jager PL: Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin Exp Rheumatol 2004; 22: S21-6.
52. Rudd JH, Warburton EA, Fryer TD et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002; 105: 2708-11.
53. Tawakol A, Migrino RQ, Bashian GG et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006; 48: 1818-24.
54. Elmaleh DR, Fischman AJ, Tawakol A et al. Detection of inflamed atherosclerotic lesions with diadenosine-5′,5″′-P1,P4-tetraphosphate (Ap4A) and positron-emission tomography. Proc Natl Acad Sci USA 2006; 103: 15992-6.
55. Davies JR, Rudd JH, Fryer TD et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 2005; 36: 2642-7.
56. Moody AR, Allder S, Lennox G, Gladman J, Fentem P: Direct magnetic resonance imaging of carotid artery thrombus in acute stroke. Lancet 1999; 353: 122-3.
57. Murphy RE, Moody AR, Morgan PS et al. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation 2003; 107: 3053-8.
58. Moody AR, Murphy RE, Morgan PS et al. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation 2003; 107: 3047-52.
59. Winter PM, Caruthers SD, Yu X et al. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003; 50: 411-6.
60. Botnar RM, Perez AS, Witte S et al. In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent. Circulation 2004; 109: 2023-9.
61. Sirol M, Fuster V, Badimon JJ et al. Chronic thrombus detection with in vivo magnetic resonance imaging and a fibrin-targeted contrast agent. Circulation 2005; 112: 1594-600.
62. Wasserman BA, Smith WI, Trout HH III, Cannon RO III, Balaban RS, Arai AE: Carotid artery atherosIlerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. Radiology 2002; 223: 566-73.
63. Yuan C, Kerwin WS, Ferguson MS et al. Contrast-enhanced high resolution MRI for atherosclerotic carotid artery tissue characterization. J Magn Reson Imaging 2002; 15: 62-7.
64. Kerwin W, Hooker A, Spilker M et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation 2003; 107: 851-6.
65. Winter PM, Morawski AM, Caruthers SD et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 2003; 108: 2270-4.
66. Sipkins DA, Cheresh DA, Kazemi MR, Nevin LM, Bednarski MD, Li KC: Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. Nat Med 1998; 4: 623-6.
67. Beer AJ, Haubner R, Wolf I et al. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression. J Nucl Med 2006; 47: 763-9.
68. Hamilton AJ, Huang SL, Warnick D et al. Intravascular ultrasound molecular imaging of atheroma components in vivo. J Am Coll Cardiol 2004; 43: 453-60.
69. Kelly KA, Allport JR, Tsourkas A, Shinde-Patil VR, Josephson L, Weissleder R: Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 2005; 96: 327-36.
70. Tsourkas A, Shinde-Patil VR, Kelly KA et al. In vivo imaging of activated endothelium using an anti-VCAM-1 magnetooptical probe. Bioconjug Chem 2005; 16: 576-81.
71. Nahrendorf M, Jaffer FA, Kelly KA et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 2006; 114: 1504-11.
72. Chen J, Tung CH, Mahmood U et al. In vivo imaging of proteolytic activity in atherosclerosis. Circulation 2002; 105: 2766-71.
73. Deguchi JO, Aikawa M, Tung CH et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation 2006; 114: 55-62.
74. Schafers M, Riemann B, Kopka K et al. Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 2004; 109: 2554-9.
75. Kolodgie FD, Petrov A, Virmani R et al. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: A technique with potential for noninvasive imaging of vulnerable plaque. Circulation 2003; 108: 3134-9.
76. Kietselaer BL, Reutelingsperger CP, Heidendal GA et al. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 2004; 350: 1472-3.
77. Hartung D, Sarai M, Petrov A et al. Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 2005; 46: 2051-6.